Uncategorized
STAAR Surgical Reports Second Quarter 2023 Results
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Overview Net Sales of $92.3 Million Up 14% includes a $0.7 Million sales reduction related to Other Products Record ICL Sales of $93.1 Million Up 19% Y/Y and Up 20% Y/Y in Constant Currency ICL Units Up 21% Y/Y Gross Margin at 76.6% vs. 78.8%